Identification of immunodominant HLA-B7-restricted CD8+ cytotoxic T cell epitopes derived from mammaglobin-A expressed on human breast cancers

Breast Cancer Research and Treatment

Volumn 127, Issue 1, 2011, Pages 81-89

  Ilias Basha, Haseeb ^a   Tiriveedhi, Venkataswarup ^a   Fleming, Timothy P ^a   Gillanders, William E ^a   Mohanakumar, T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD8 T cell; Mammaglobin A; Vaccine

Indexed keywords

CD8 ANTIGEN; EPITOPE; HLA B7 ANTIGEN; MAMMAGLOBIN; MAMMAGLOBIN A; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL CULTURE; CAUCASIAN; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GENE FREQUENCY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MEMBRANE STABILIZATION; POPULATION GENETICS; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; BREAST NEOPLASMS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; FEMALE; HLA-B7 ANTIGEN; HUMANS; NEOPLASM PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; UTEROGLOBIN;

EID: 79954640599     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0975-z     Document Type: Article

References (33)

1. MA Watson TP Fleming 1994 Isolation of differentially expressed sequence tags from human breast cancer Cancer Res 54 17 4598 4602 8062249 1:CAS:528:DyaK2cXmtVajsrw%3D (Pubitemid 24276479)
2. TP Fleming MA Watson 2000 Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer Ann N Y Acad Sci 923 78 89 11193781 10.1111/j.1749-6632.2000.tb05521.x 1:CAS:528:DC%2BD3MXnt1aqsA%3D%3D (Pubitemid 32050207)
3. PS Goedegebuure MA Watson CT Viehl TP Fleming 2004 Mammaglobin-based strategies for treatment of breast cancer Curr Cancer Drug Targets 4 6 531 542 15462037 10.2174/1568009043332862 1:CAS:528:DC%2BD2cXotV2luro%3D (Pubitemid 39304496)
4. MA Watson TP Fleming 1996 Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer Cancer Res 56 4 860 865 8631025 1:CAS:528:DyaK28XhtVCltr4%3D (Pubitemid 26055478)
5. K Mikhitarian WE Gillanders JS Almeida R Hebert Martin JC Varela JS Metcalf DJ Cole M Mitas 2005 An innovative microarray strategy identities informative molecular markers for the detection of micrometastatic breast cancer Clin Cancer Res 11 10 3697 3704 15897566 10.1158/1078-0432.CCR-04-2164 1:CAS:528:DC%2BD2MXktFyrt70%3D (Pubitemid 40685586)
6. MA Watson S Dintzis CM Darrow LE Voss J DiPersio R Jensen TP Fleming 1999 Mammaglobin expression in primary, metastatic, and occult breast cancer Cancer Res 59 13 3028 3031 10397237 1:CAS:528:DyaK1MXksVClu7k%3D (Pubitemid 29315994)
7. WE Gillanders K Mikhitarian R Hebert PD Mauldin Y Palesch C Walters MM Urist GB Mann G Doherty VM Herrmann, et al. 2004 Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study Ann Surg 239 6 828 837 15166962 10.1097/01.sla.0000128687.59439.d6 (discussion 837-840) (Pubitemid 38669433)
8. DJ Slamon W Godolphin LA Jones JA Holt SG Wong DE Keith WJ Levin SG Stuart J Udove A Ullrich, et al. 1989 Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer Science 244 4905 707 712 2470152 10.1126/science.2470152 1:STN:280:DyaL1M3kt1Wntg%3D%3D (Pubitemid 19147683)
9. JJ Donnelly JB Ulmer JW Shiver MA Liu 1997 DNA vaccines Annu Rev Immunol 15 617 648 9143702 10.1146/annurev.immunol.15.1.617 1:CAS:528:DyaK2sXisVCmtLs%3D (Pubitemid 27169294)
10. S Gurunathan DM Klinman RA Seder 2000 DNA vaccines: immunology, application, and optimization Annu Rev Immunol 18 927 974 10837079 10.1146/annurev.immunol.18.1.927 1:CAS:528:DC%2BD3cXjs1Gmt7w%3D (Pubitemid 30365401)
11. R Wang DL Doolan TP Le RC Hedstrom KM Coonan Y Charoenvit TR Jones P Hobart M Margalith J Ng, et al. 1998 Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine Science 282 5388 476 480 9774275 10.1126/science.282.5388.476 1:CAS:528:DyaK1cXmsleisr8%3D (Pubitemid 28483675)
12. RR MacGregor JD Boyer KE Ugen KE Lacy SJ Gluckman ML Bagarazzi MA Chattergoon Y Baine TJ Higgins RB Ciccarelli, et al. 1998 First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response J Infect Dis 178 1 92 100 9652427 1:CAS:528:DyaK1cXksVSlt7w%3D (Pubitemid 28328080)
13. KE Ugen SB Nyland JD Boyer C Vidal L Lera S Rasheid M Chattergoon ML Bagarazzi R Ciccarelli T Higgins, et al. 1998 DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans Vaccine 16 19 1818 1821 9795386 10.1016/S0264-410X(98)00180-7 1:CAS:528:DyaK1cXntVOht7s%3D (Pubitemid 28473921)
14. M Pavlenko AK Roos A Lundqvist A Palmborg AM Miller V Ozenci B Bergman L Egevad M Hellstrom R Kiessling, et al. 2004 A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer Br J Cancer 91 4 688 694 15280930 1:CAS:528:DC%2BD2cXmsVCgsb0%3D (Pubitemid 39141625)
15. K Narayanan A Jaramillo ND Benshoff LG Campbell TP Fleming JR Dietz T Mohanakumar 2004 Response of established human breast tumors to vaccination with mammaglobin-A cDNA J Natl Cancer Inst 96 18 1388 1396 15367572 10.1093/jnci/djh261 1:CAS:528:DC%2BD2cXns1Omtbs%3D (Pubitemid 39406173)
16. PP Manna A Jaramillo K Majumder LG Campbell TP Fleming JR Dietz JF Dipersio T Mohanakumar 2003 Generation of CD8 + cytotoxic T lymphocytes against breast cancer cells by stimulation with mammaglobin-A-pulsed dendritic cells Breast Cancer Res Treat 79 1 133 136 12779090 10.1023/A:1023323509888 1:CAS:528:DC%2BD3sXivFOit7c%3D (Pubitemid 36561051)
17. A Jaramillo K Majumder PP Manna TP Fleming G Doherty JF Dipersio T Mohanakumar 2002 Identification of HLA-A3-restricted CD8 + T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer Int J Cancer 102 5 499 506 12432553 10.1002/ijc.10736 1:CAS:528: DC%2BD38XovVOksLg%3D (Pubitemid 35316005)
18. A Jaramillo K Narayanan LG Campbell ND Benshoff L Lybarger TH Hansen TP Fleming JR Dietz T Mohanakumar 2004 Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8 + cytotoxic T lymphocytes from breast cancer patients Breast Cancer Res Treat 88 1 29 41 15538043 10.1007/s10549-004- 8918-1 1:CAS:528:DC%2BD2cXpsF2mtrs%3D (Pubitemid 39524442)
19. SE Burdall AM Hanby MR Lansdown V Speirs 2003 Breast cancer cell lines: friend or foe? Breast Cancer Res 5 2 89 95 12631387 10.1186/bcr577 (Pubitemid 36348102)
20. F Gronen K Ruprecht B Weissbrich E Klinker A Kroner HH Hofstetter P Rieckmann 2006 Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls J Neuroimmunol 180 1-2 185 192 17023054 10.1016/j.jneuroim. 2006.08.008 1:CAS:528:DC%2BD28Xht1SmsLzO (Pubitemid 44692331)
21. KD Smith CT Lutz 1996 Peptide-dependent expression of HLA-B7 on antigen processing-deficient T2 cells J Immunol 156 10 3755 3764 8621911 1:CAS:528:DyaK28XivVamsrg%3D (Pubitemid 26137661)
22. JJ Kuhns MA Batalia S Yan EJ Collins 1999 Poor binding of a HER-2/neu epitope (GP2) to HLA-A2.1 is due to a lack of interactions with the center of the peptide J Biol Chem 274 51 36422 36427 10593938 10.1074/jbc.274.51.36422 1:CAS:528:DC%2BD3cXit1Sk (Pubitemid 30005249)
23. Y Tanaka KD Amos HG Joo TJ Eberlein PS Goedegebuure 2001 Modification of the HER2/NEU-derived tumor antigen GP2 improves induction of GP2-reactive cytotoxic T lymphocytes Int J Cancer 94 4 540 544 11745441 10.1002/ijc.1508 1:CAS:528:DC%2BD3MXns1Gnuro%3D (Pubitemid 32979546)
24. DR Flower 2003 Towards in silico prediction of immunogenic epitopes Trends Immunol 24 12 667 674 14644141 10.1016/j.it.2003.10.006 1:CAS:528:DC%2BD3sXptlyhsrw%3D (Pubitemid 37492876)
25. W Liu X Meng Q Xu DR Flower T Li 2006 Quantitative prediction of mouse class I MHC peptide binding affinity using support vector machine regression (SVR) models BMC Bioinformatics 7 182 16579851 10.1186/1471-2105-7-182 (Pubitemid 44110265)
26. S Earley GE Plopper 2006 Disruption of focal adhesion kinase slows transendothelial migration of AU-565 breast cancer cells Biochem Biophys Res Commun 350 2 405 412 17010315 10.1016/j.bbrc.2006.09.056 1:CAS:528: DC%2BD28XhtVCrtr%2FO (Pubitemid 44515086)
27. NT Ueno C Bartholomeusz W Xia P Anklesaria EM Bruckheimer E Mebel R Paul S Li GH Yo L Huang, et al. 2002 Systemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A gene Cancer Res 62 22 6712 6716 12438271 1:CAS:528:DC%2BD38XovFOksLc%3D (Pubitemid 35364142)
28. S Lee-Huang PL Huang Y Sun HC Chen HF Kung PL Huang WJ Murphy 2000 Inhibition of MDA-MB-231 human breast tumor xenografts and HER2 expression by anti-tumor agents GAP31 and MAP30 Anticancer Res 20 2A 653 659 10810336 1:CAS:528:DC%2BD3cXjsVersLc%3D (Pubitemid 30240615)
29. L Zuo L Li Q Wang TP Fleming S You 2009 Mammaglobin as a potential molecular target for breast cancer drug delivery Cancer Cell Int 9 8 19309500 10.1186/1475-2867-9-8
30. MA Watson C Darrow DB Zimonjic NC Popescu TP Fleming 1998 Structure and transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin gene family localized to chromosome 11q13 Oncogene 16 6 817 824 9488047 10.1038/sj.onc.1201597 1:CAS:528: DyaK1cXhtlGgtL8%3D (Pubitemid 28076094)
31. JG Bodmer SG Marsh ED Albert WF Bodmer RE Bontrop D Charron B Dupont HA Erlich R Fauchet B Mach, et al. 1997 Nomenclature for factors of the HLA system, 1996 Tissue Antigens 49 3 Pt 2 297 321 9098945 10.1111/j.1399-0039.1997. tb02759.x 1:CAS:528:DyaK2sXitlOksr8%3D (Pubitemid 27122302)
32. CJ Luckey JA Marto M Partridge E Hall FM White JD Lippolis J Shabanowitz DF Hunt VH Engelhard 2001 Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors J Immunol 167 3 1212 1221 11466336 1:CAS:528:DC%2BD3MXls1Wktb0%3D (Pubitemid 32703115)
33. G Berke 1994 The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects Annu Rev Immunol 12 735 773 8011296 10.1146/annurev.iy.12.040194.003511 1:CAS:528:DyaK2cXivFKisrw%3D (Pubitemid 24140430)